NovaBridge Biosciences (NBP) Financials

NBP Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 37.2 million 4.2 million
Dec. 31, 2025 37.2 million 4.2 million
Sept. 30, 2025 14.1 billion 131.7 million
June 30, 2025 206.7 million 1.4 million

NBP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -14.6 million 3.9 million
Dec. 31, 2025 -14.6 million 3.9 million
Sept. 30, 2025 13.1 million 10.4 million
June 30, 2025 ? 2.1 million

NBP Net Income

No data available :(

NBP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 30.1 million - -
Dec. 31, 2025 30.1 million - 438457
Sept. 30, 2025 11.6 billion - 23.3 million
June 30, 2025 165.6 million - 3.5 million

NBP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 50.2 million
Dec. 31, 2025 265.4 million
Sept. 30, 2025 43.9 million
June 30, 2025 81.7 million

NBP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 8.0 million 2.5 million -
Dec. 31, 2025 - 8.0 million 2.5 million -
Sept. 30, 2025 5 446098 816490 -
June 30, 2025 - 459792 533213 -

NBP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 216942
Dec. 31, 2025 - -
Sept. 30, 2025 238.0 million 216289
June 30, 2025 - -

NBP

Price: $1.98

52 week price:
1.46
6.79

Earnings Per Share: -0.49 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 190.8 million

Links: